Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

375
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

356
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
356
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

333
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
333
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

345
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
345
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

357
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
357
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polypoid colon mucosa in a leukemia patient.

Acta gastro-enterologica Belgica·2022
Same author

Correction to: Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2021
Same author

Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma.

European journal of nuclear medicine and molecular imaging·2020
Same author

Aviation Cardiology.

European heart journal·2019
Same author

Relating the MNA Mobility Single Item to Usual Walking Speed in Hospitalized and Community-Dwelling Geriatric Patients.

The Journal of frailty & aging·2019
Same author

Orthostatic blood pressure drop and cardiovascular and psychotropic medication dosages in acutely ill geriatric inpatients.

Acta clinica Belgica·2019

Related Experiment Video

Updated: Apr 17, 2026

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.7K

[Anemia in the elderly].

M Maerevoet, L Sattar, D Bron

    Revue Medicale De Bruxelles
    |February 14, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Anemia in older adults signals underlying disease, not aging. Prompt diagnosis and treatment of its complex causes are crucial for better health outcomes and reduced mortality risks.

    More Related Videos

    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
    12:59

    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

    Published on: July 5, 2017

    13.4K

    Related Experiment Videos

    Last Updated: Apr 17, 2026

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
    05:35

    Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

    Published on: January 19, 2024

    1.7K
    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
    12:59

    Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

    Published on: July 5, 2017

    13.4K

    Area of Science:

    • Gerontology
    • Hematology
    • Internal Medicine

    Context:

    • Anemia affects a significant portion of the elderly population, with prevalence increasing with advanced age.
    • Unlike physiological aging, anemia in seniors indicates an underlying pathological condition.
    • Elderly anemia is linked to poorer prognosis, including increased mortality, morbidity, and frailty.

    Purpose:

    • To highlight that anemia in the elderly is always pathological.
    • To emphasize the diagnostic approach and multifactorial etiology of anemia in older individuals.
    • To discuss treatment considerations specific to elderly patients.

    Summary:

    • Anemia is not a normal part of aging; it signifies an underlying disease process in older adults.
    • The diagnostic workup for anemia in the elderly is similar to younger individuals, focusing on deficiency, inflammation, or comorbidities.
    • Etiologies are often multifactorial and can remain unexplained, necessitating tailored treatment strategies, including iron substitution or erythropoietin (EPO).

    Impact:

    • Underscores the importance of investigating anemia in the elderly to identify and manage serious underlying conditions.
    • Informs clinical practice regarding the diagnostic and therapeutic nuances of anemia in geriatric populations.
    • Aims to improve patient outcomes by emphasizing that anemia is treatable and not an inevitable consequence of aging.